News and Trends 30 Sep 2024
The race for a bird flu vaccine: milestones and breakthroughs
The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
News and Trends 27 Sep 2024
Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders
Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with.
Best in Biotech 26 Sep 2024
Europe’s rising biotech stars: 10 startups to watch in 2024
The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash.
In Depth 20 Sep 2024
Mitigating hot flashes: new therapies for menopause on the rise
New therapies could address menopause symptoms, a field in which many treatment gaps still exist.
In Depth 19 Sep 2024
Mitochondrial disease treatments: is a breakthrough on the horizon?
Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.
In Depth 12 Sep 2024
New treatments being developed for schizophrenia
Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 10 Sep 2024
Long non-coding RNAs: what’s behind the growing “dark genome” buzz?
Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front.
Best in Biotech 5 Sep 2024
Six biotech companies that could revolutionize obesity treatments
In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.
News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
News and Trends 28 Aug 2024
GLP-1 shortage: Can biotech companies keep up with rising demand?
How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.
News and Trends 20 Aug 2024
Fighting mpox: promising vaccines to watch
As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak.
News and Trends 14 Aug 2024
CAR-T drugs and parkinsonism: a cause for concern?
CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt.
ADVERTISEMENT
